PerkinElmer to Pay Enzo Biochem $7M to Settle IP Suit | GenomeWeb

NEW YORK (GenomeWeb) – Enzo Biochem today said that PerkinElmer will pay the firm $7 million as part of a legal settlement reached between the firms last week.

The settlement ends a patent dispute dating back more than a decade. PerkinElmer was one of several defendants named by Enzo in a patent infringement suit initially filed in 2002 in the US District Court for the Southern District of New York. The case surrounded patents licensed to Enzo covering the labeling, hybridizing, and detection of nucleotides.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: variation patterns in wheat lines, regulatory variation in Capsella grandiflora, and more.

A Rockefeller University researcher is using edited ants to explore complex biological systems, the New York Times writes.

There's a heritable aspect to how much time people spend online, the Los Angeles Times reports.

Stat News reports that Joseph Gulfo is another contender for FDA commissioner.